ascopubs.org6d
Business of Health Care and the Personal Cost of Cancer Care
The following represents disclosure information provided by the author of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted ...
ascopubs.org6d
Financial Toxicity in Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series
With this special issue of JCO Oncology Practice focused on financial toxicity, we sought to keep an intentionality with looking forward to the next steps for advancing the field, promoting innovative ...
ascopubs.org3d
Targeting CD30 in Diffuse Large B-Cell Lymphoma: Where Does It Fit in?
ALK Tyrosine Kinase Inhibitors Induced Weight Gain: More Refined Definition of Weight Gain, Glucagon-Like Peptide-1 Agonist Treatment, and Therapeutic Drug Monitoring of ALK+ Non–Small Cell Lung ...
ascopubs.org4d
Novel Treatment Options for Multiple Myeloma
Treatment Patterns and Costs Among Patients With Metastatic Renal Cell Carcinoma in the United States: A Real-World Study Using Integrated Claims and Clinical Data Multiple myeloma (MM), the second ...
ascopubs.org4d
Defining and Measuring Financial Toxicity in Low- and Middle-Income Countries
Following PRISMA guidelines, we searched MEDLINE, Web of Science, and CINAHL for FT literature in cancer originating from LMICs from inception until the end of 2023, and documented the different ...
ascopubs.org6d
Addressing Financial Toxicity From a Global Perspective: How to Advance Shared-Learning to Facilitate Change?
Addressing Financial Toxicity From a Global Perspective: How to Advance Shared-Learning to Facilitate Change? The following represents disclosure information provided by authors of this manuscript.
ascopubs.org4d
Financial Toxicity Has Never Been More Important in Cancer Care: How Do We Measure It?
Financial Toxicity Has Never Been More Important in Cancer Care: How Do We Measure It? The following represents disclosure information provided by authors of this manuscript. All relationships are ...
ascopubs.org6d
Debt or Dying: The High Costs of Cancer Care in America, One Patient's Perspective
My name is Kelly Shanahan and I have been living with—or as I like to say #NotDeadYet—with metastatic breast cancer (MBC) for 10 years. In 2008, I had everything going for me: a graduate of Bryn Mawr ...
ascopubs.org6d
Errata: Waiting to Exhale: The Feasibility and Appropriateness of Home Blood Oxygen Monitoring in Oncology Patients Post–Hospital Discharge
The article by Liu et al entitled “Waiting to Exhale: The Feasibility and Appropriateness of Home Blood Oxygen Monitoring in Oncology Patients Post–Hospital Discharge” (JCO Clinical Cancer Informatics ...
ascopubs.org6d
Business of Health Care and the Personal Cost of Cancer Care
Associations of Financial Hardship and Health Status, Social Functioning, and Mental Health Among Cancer Survivors in the United States: Findings From a Nationally Representative Study The following ...
ascopubs.org6d
Financial Toxicity Has Never Been More Important in Cancer Care: How Do We Measure It?
Fig 1. The COST development citations according to year from 2014 to 2023 (total N = 395). COST, Comprehensive Score for Financial Toxicity. Fig 2. The 2017 COST validation citations according to year ...
ascopubs.org6d
The Price Is NOT Right: Payers’ Roles in Addressing Financial Toxicity
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...